Lexicon Pharmaceuticals LXRX Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's interest paid?
- Lexicon Pharmaceuticals (LXRX) reported interest paid of $1.48M in Q1 2026.
- How has Lexicon Pharmaceuticals's interest paid changed year-over-year?
- Lexicon Pharmaceuticals's interest paid decreased by 50.2% year-over-year, from $2.97M to $1.48M.
- What is the long-term trend for Lexicon Pharmaceuticals's interest paid?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's interest paid has grown at a 79.7% compound annual growth rate (CAGR), from $799K to $8.33M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.